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CASE REPORT

GIANT CELL TUMOUR OF THE SACRUM: FUNCTION-PRESERVING
SURGERY WITH EXTENDED CURETTAGE AND ILIO-LUMBAR
FUSION
Riaz H. Lakdawala, Tashfeen Ahmad, Syed A. Enam,*
Departments of Surgery and Biological and Biomedical Sciences, Aga Khan University, Karachi, Pakistan

Giant cell tumours of the sacrum pose a unique therapeutic challenge due to the inaccessibility of
the tumour, significant intra-operative blood loss from extensive vascularity, high rate of local
recurrence with conservative surgery, and loss of neurological function and mechanical instability
with en-bloc excision. We present a case where successful outcome was achieved by tailoring
treatment in consideration of the above issues. A 28 year old male diagnosed on biopsy to have
giant cell tumour of the sacrum presented to us with low-back pain, left-sided S1 radiculopathy,
ankle weakness and urinary incontinence. MRI showed a tumour involving the S1 and S2
vertebral segments, breaching the posterior cortex and compressing the neural elements. An
angiographic tumour embolization was performed followed by surgery through a posterior
approach whereby an extended curettage was done, carefully freeing the sacral nerve roots and
abrading the bone using high-speed burr. An ilio-sacro-lumbar fusion was done employing iliolumbar instrumentation and bone grafting. Post-operatively, within a week the patient was
ambulated with a lumbar corset. At 9 months follow-up, the patient was completely pain free, had
no ankle weakness, and had normal continence. This treatment approach resulted in preservation
of neurologic function and maintenance of spinal stability, thus the patient returned to full
function.
Keyword: Giant cell tumour of bone; sacrum; selective arterial embolization; extended curettage;
ilio-lumbar fusion; segmental instrumentation.
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INTRODUCTION
Sacrum is the fourth most common site affected by giant
cell tumour of bone and carries a 23% mortality rate.1
There is no consensus regarding optimal management.
Conventionally, giant cell tumours are treated surgically
by curettage and bone grafting, but such intralesional
excision results in 47% recurrence rate. Adjuvants such
as electrocautery, phenol and bone cement are therefore
used to reduce the risk of recurrence, but in the spine
they pose a risk of injury to the neural elements.
Moreover, difficulty in surgical treatment of giant cell
tumours involving the sacrum also stem from the
inaccessibility of the tumour, significant intra-operative
blood loss due to extensive vascularity and postoperative mechanical lumbo-sacro-pelvic instability.
Thus, sacral giant cells tumours pose a unique
therapeutic challenge and necessitate a modified
management approach to preserve neurological and
mechanical function. We present a case of giant cell
tumour of the sacrum where successful outcome was
achieved by tailoring treatment in consideration of these
concepts.

CASE
The patient was a 28 year old male who was initially
evaluated outside our hospital for symptoms of leftsided S1 radiculopathy. An MRI was done (Figure-1)
which showed a tumour involving the S1 and S2
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vertebral segments, breaching the posterior cortex and
compressing the neural elements (Campanacci stage
III).2 He underwent a left-S1 laminectomy and open
biopsy in an outside hospital; the biopsy was reported as
giant cell tumour. The patient continued to have pain
and also developed urinary and bowel incontinence and
ankle weakness, with which he presented to us.
Examination revealed restricted straight leg raising test
(R) 40°, (L) 30°, reduced sensation along S1, absent
ankle jerks, absent perianal sensation and lax anal
sphincter. CT scan showed tumour extending into the
neural canal posteriorly from S1 and S2 sacral
segments, and the previous left S1 laminectomy
(Figure-2). MRI scan demonstrated local progression of
the tumour as compared to the initial scan (Figure-3),
approaching the sacro-iliac and lumbo-sacral joints.
A preoperative angiography was performed,
showing a tumour blush with feeding arteries coming
from branches of the internal iliac arteries on both sides.
Angiographic embolization of these tumour vessels was
performed, with complete disappearance of the tumour
blush (Figure-4). Subsequently, surgery was done
through a posterior approach whereby an extended
curettage was done. Blunt and sharp dissection was
done to free the sacral nerve roots from the tumour,
while the bone was abraded using high-speed burr. In
order to prevent pistoning of the lumbar spine into the
weakened sacrum, an ilio-lumbar instrumentation using
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a construct of pedicle screws in the L4 and L5 vertebrae
as well as both iliac crests, attached to contoured rods
interconnected with a cross-link (Figure-5). Fibular and
iliac bone grafting was done. Post-operatively, within a
week the patient was ambulated with a lumbar corset.
At 9 months follow-up, the patient was completely pain
free, had no weakness of ankle plantar flexion (Figure6), and had normal bladder and bowel continence.

DISCUSSION
Although locally advanced giant cell tumours of the
sacrum pose a difficult surgical challenge, our case
illustrates a practical approach which has proven
successful in eliminating the disease while preserving
mechanical and neurological functions. In spinal tumours,
non-operative treatment in the form of radiotherapy can
be used as solitary treatment for inaccessible lesions, but
there is up to 49% recurrence rate and a risk of late
malignant transformation. There have been some recent
developments in this modality, such as “megavoltage
radiotherapy”. This entails administration of 30–70 gray
over 5–7 weeks as the solitary treatment, and has been
reported to give 85% non-progression of tumour at 10
years.3 Angio-embolization has also been used as a
solitary procedure, but is fraught with a 30% recurrence
rate at 10 years and 43% at 20 years.4,5 However, when
used pre-operatively, it significantly reduces intraoperative bleeding and reduces surgical difficulty. Thus,

surgical excision remains the mainstay of treatment of
sacral giant cell tumours.6,7 Intra lesional curettage has
been the gold standard for non-spinal lesions, but in the
spine it is known to result in a high rate of local
recurrence. The risk of local recurrence can only be
eliminated by en bloc excision of the involved bone.
However, en bloc excision is not the optimal treatment
method in regions such as the sacrum because important
neural elements lie within the bone. Moreover, if the
neural canal is encroached upon by the tumour, during
curettage it is not possible to use adjuvants because they
would injure the nerves. Injury to S1 nerve roots results
in loss of ankle plantar-flexion power required for
normal gait, and injury to S2 nerve roots results in loss
of bladder and bowel sphincter control. Thus, the use of
intra-operative magnification and micro-dissection
technique around the neural elements, and use of high
speed burr and electrocautery in the margins help to
reduce the residual tumour cells. En bloc excision as
well as extensive intralesional curettage result in
mechanical instability for which lumbo-sacro-pelvic
reconstruction is recommended.8 In consideration of the
above factors, we treated our patient with preoperative
angio-embolization followed by surgery which entailed
curettage and careful dissection to free the neural
elements and use of high-speed burr on the margins of
resection, and reconstruction with lumbo-sacro-pelvic
instrumented fusion.
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Figure-1: (A, B). Sagittal T-2 (A) and axial T-1 (B) weighted images from initial MRI scan showing expansile
tumour (arrows) involving sacral segments S1 and S2 and bulging into the neural canal
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Figure-2: (A,B). CT scan images showing (A) Campanacci III lesion extending into the neural canal
posteriorly from sacral segments S1 and S2 (arrow). 3-D reconstruction of sacrum viewed from behind (B)
demonstrating previous left S1 laminectomy (arrow)
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Figure-3: (A, B) Images from MRI scan performed post-S1 laminectomy, sagittal (A) and axial (B) views,
demonstrating tumour extension into the neural canal (arrows) adjacent S1 and S2 segment

Figure-4: (A-D) Angiographic tumour embolization of lateral sacral arteries. (A, C) Pre-embolization images
showing tumour blush (arrows) arising from branches from the left (A) and right (C) lateral sacral arteries.
(B, D) Post-embolization images demonstrating disappearance of tumour blush (arrows)

Figure-5: (A,B): (A) Per-operative AP and lateral X-rays showing iliolumbar instrumentation and bone
grafting. (B) Follow-up X-rays performed nine months after surgery showing satisfactory fusion

Figure-6: Clinical pictures showing preservation of lumbosacral contour and intact S1 function (toe-walk)
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CONCLUSION
The treatment method employed in our patient
resulted in preservation of neurologic function and
maintenance of lumbo-sacro-pelvic stability, thus the
patient became symptom-free and returned to full
function. A multi-modal therapeutic approach is
warranted in the management of giant cell tumours of
the sacrum.
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